TrialAmerican journal of clinical dermatology2026

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.

Tiffany Mayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.